Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,844 total articles
Rapid7, a leader in AI-powered managed cybersecurity operations, announced it will release its first quarter 2026 financial results after market close on May 5, 2026. The company will hold a conference call the same day to discuss performance and outlook.
Zentalis Pharmaceuticals announced the selection of the 400mg once daily on a 5-days-on, 2-days-off dosing regimen of their investigational drug azenosertib for use in Cyclin E1-positive platinum-resistant ovarian cancer. The decision is based on positive interim data from the DENALI Part 2a Phase 2 clinical trial showing improved response rates at…
Commerce.com, Inc., a Nasdaq-listed company specializing in AI-driven commerce ecosystems, announced it will host an investor briefing during the 2026 Commerce Live leadership conference in Chicago. The event will include presentations and Q&A sessions with company leadership and will be available via webcast.
Trident Digital Tech Holdings Ltd (Nasdaq: TDTH) announced a strategic partnership with U.S.-Israeli cybersecurity firm Memcyco to launch the first AI-driven preemptive fraud defense solution in the Asia-Pacific region. The integrated solution combines Memcyco's real-time threat detection with Trident's blockchain-based identity platform, enabling …
Coherent Corp. announced advancements in silicon carbide thick epitaxy capabilities, enabling production of power devices supporting voltages up to 10kV, aimed at enhancing efficiency and power density in next-generation AI datacenters and various industrial power applications. This technological leap supports the growing demand for efficient high-…
Northern Technologies International Corporation reported its financial results for the second quarter of fiscal year 2026, with consolidated net sales rising 15.3% year-over-year to a record $22 million. Key growth drivers included an 72.1% increase in ZERUST® oil and gas sales, 18.5% growth in China operations, and 8.1% increase in Natur-Tec® prod…
Crane NXT, a global leader in authentication and traceability technologies, announced its first quarter 2026 earnings release date as May 6, 2026, after market close, followed by an earnings call on May 7, 2026. The company provides solutions to prevent counterfeiting and ensure product authenticity across supply chains.
AppFolio, Inc. announced that it will release its Q1 2026 financial results after market close on April 23, 2026. The company will hold a conference call the same day to discuss financial outcomes and business outlook. Investors can access the call via webcast or phone.
Credit Acceptance Corporation has been named a 2026 USA Today Top Workplaces award winner for the sixth consecutive year, ranking #4 in its employee size category. The company is also recognized in the Well-Being specialty category, highlighting its commitment to employee engagement, remote work flexibility, and a positive workplace culture. This f…
Rhythm Pharmaceuticals, the commercial-stage biopharmaceutical company focused on rare neuroendocrine diseases, announced it will report its Q1 2026 financial results on May 5, 2026, and participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 16, 2026. Their lead product, IMCIVREE (setmelanotide), is approve…
Perpetuals.com Ltd announced a strategic initiative to license and deploy Forgentiq.ai, an exclusive on-premises agentic AI platform tailored for hedge funds, proprietary trading firms, and digital asset managers. The platform focuses on data sovereignty by operating within clients' secure environments, enabling advanced quantitative research and t…
Nautilus Biotechnology, a development stage life sciences firm specializing in proteomics technology, announced it will report its first quarter 2026 financial results on April 28, 2026. The company will host a webcast and conference call to discuss its results, business developments, and outlook.
Cardiff Oncology, a clinical-stage biotech company developing PLK1 inhibitors for cancer treatment, announced key executive appointments to support its next growth phase. Mani Mohindru, PhD, was named President and CEO after serving as Interim CEO. Industry veterans Josh Muntner and Ajay Aggarwal, MD, MBA, joined as CFO and COO, respectively. These…
Seer, Inc. announced that its Proteograph Product Suite was selected to provide deep, unbiased proteomic profiling for 10,000 participants in Singapore's PRECISE-SG100K multi-ancestry cohort study. Integrating proteomics data with genomics and other health data, this collaboration aims to advance precision medicine and biomarker validation in diver…
LOBO TECHNOLOGIES LTD., a Nasdaq-listed electric mobility manufacturer, announced the launch of its Claw AI Agent Platform tailored for export-oriented manufacturing. The platform integrates advanced AI models to enhance processes like customer acquisition, order management, and supply chain coordination, aiming to accelerate digital transformation…
Kestra Medical Technologies, a Nasdaq-listed wearable medical device and digital healthcare company, announced it has been named a 2026 USA TODAY Top Workplaces award winner based on employee feedback highlighting strong culture, engagement, and leadership. The recognition underscores Kestra's commitment to its team and mission to improve patient o…
Amneal Pharmaceuticals has launched its generic version of bimatoprost ophthalmic solution 0.01%, a treatment for elevated intraocular pressure in glaucoma and ocular hypertension patients. The product is the generic equivalent of Allergan's LUMIGAN® 0.01%, which had annual U.S. sales of approximately $719 million for the year ended February 2026. …
Alignment Healthcare, Inc. announced it will release its Q1 2026 financial results after market close on April 30, 2026, followed by a conference call to discuss the results. The company focuses on providing coordinated, low-cost care to Medicare Advantage members through its technology-driven care model and expanding national footprint.
CCC Intelligent Solutions Holdings Inc. announced that it will release its financial results for the first quarter of 2026 on April 30, 2026, and host a conference call to discuss the results and business outlook. The company is a leading cloud platform provider for the insurance economy, leveraging AI to connect various industry participants.
Gentherm announced it will release its first quarter 2026 financial results on April 23, 2026, accompanied by a conference call to discuss the results. The company is a global leader in thermal management and pneumatic comfort technologies, serving automotive and medical sectors with innovative products and has generated significant new business aw…
NXP Semiconductors announced it will release its first quarter 2026 financial results on April 28, 2026, followed by a conference call with the financial community to discuss the results. The company reported revenue of $12.27 billion for 2025 and operates across automotive, industrial & IoT, mobile, and communications infrastructure markets.
Rocket Lab Corporation has signed a contract to provide three new dedicated Electron rocket launches for the Institute for Q-shu Pioneers of Space (iQPS), increasing their total Electron missions for iQPS to 15. This extension of their partnership highlights continued strong demand for Rocket Lab's launch services to deploy small satellite constell…
Kyverna Therapeutics announced a conference call to discuss new clinical trial data for miv-cel, its autologous CD19-targeting CAR T-cell therapy, in stiff person syndrome and generalized myasthenia gravis, with data being presented at the American Academy of Neurology Annual Meeting. The data includes primary analysis from the registrational KYSA-…
Village Farms International, Inc. has launched a pilot program through its Pure Sunfarms brand to introduce THC potency range labeling on cannabis flower packaging in British Columbia, marking the first such initiative in the Canadian recreational cannabis market. This move builds on the company’s research into THC variability, aiming to more accur…
AIM ImmunoTech Inc. announced that CEO Thomas K. Equels will participate in a live virtual investor Closing Bell event on April 16, 2026. The event will include a presentation on the company's corporate overview, business outlook, and a Q&A session. AIM ImmunoTech focuses on developing Ampligen for late-stage pancreatic cancer treatment.
